ALUMIS INC.
ALMS$183M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSOUTH SAN FRANCISCO
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
2
Next Catalyst
Aug 12, 2026
7wMarket Overview
Stock performance and key metrics
ALMS News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
Open-Label ESK-001
Plaque Psoriasis
ESK-001
Plaque Psoriasis
Apremilast
Plaque Psoriasis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Open-Label ESK-001 | Phase 3 | Plaque Psoriasis | - | - |
ESK-001 | Phase 3 | Plaque Psoriasis | - | - |
Apremilast | Phase 3 | Plaque Psoriasis | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply